Clinical Trial Update: An Open-Label Trial of Memantine in the Treatment of Binge Eating Disorder [Phase 4]

View source ↗

Summary

The document reports the completion of an open-label Phase 4 trial evaluating memantine for binge eating disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Binge Eating Disorder

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: Mclean Hospital | Conditions: Binge Eating Disorder | Phase 4 | Status: COMPLETED